ATRX and oligodendroglioma: Although the entity of “oligodendroglioma, IDH wildtype and 1p/19q codeleted” only accounts for a very small percentage, we argue that such entity should be added to the pathological diagnosis category, and further exploration of other novel molecular markers is needed for characterization besides ATRX and TERT.